José Luis Ferreiro: After Stent Treatment in Heart Attack Patients How to Balance Bleeding and Clotting Risk
José Luis Ferreiro, Head of the Department of Cardiology at Hospital Universitari Joan XXIII, shared a post on LinkedIn about a recent article he and his colleagues co-authored, adding:
”Happy to share this new Clinical Consensus Statement led by the ESC Working Group on Thrombosis in collaboration with ACCA, EAPCI and Working Group on Cardiovascular Pharmacotherapy
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks.
Simultaneous publication in European Heart Journal: Acute Cardiovascular Care and EuroIntervention
Discussing alternative antithrombotic strategies to standard DAPT to reduce bleeding (DAPT abbreviation and de-escalation) or ischaemic (prolonged DAT) risk and some guidance to individualize therapy.”
Erik Lerkevang Grove, Cardiologist at Aarhus University Hospital, Skejby shared this post on LinkedIn, adding:
”Proud to be part of this important and comprehensive consensus document:
Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks
Simultaneous publication in European Heart Journal: Acute Cardiovascular Care and EuroIntervention.”
Title: Antithrombotic therapy for secondary prevention in patients with acute coronary syndromes treated with percutaneous coronary intervention: options for personalization to reduce bleeding or ischaemic risks: A Clinical Consensus Statement of the ESC Working Group on Thrombosis, the Association for Acute CardioVascular Care of the ESC, the European Association of Percutaneous Cardiovascular Interventions of the ESC, and the ESC Working Group on Cardiovascular Pharmacology
Authors: Diana A Gorog, Jurrien M ten Berg, Gianluca Campo, Tobias Geisler, Bruna Gigante, Erik L Grove, Sigrun Halvorsen, Kurt Huber, Young-Hoon Jeong, Gregory Y H Lip, Eliano P Navarese, Andrea Rubboli, Jolanta M Siller Matula, Robert F Storey, Marco Valgimigli, Christophe Vandenbriele, Gemma Vilahur, Ingo Ahrens, Jose Luis Ferreiro
Read the Full Article on European Heart Journal Acute Cardiovascular Care
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 26, 2026, 18:01Sam Tsimikas: Lp(a) and Oxidized Phospholipids Reveal a New Link Between Hypercoagulability and Stronger Clot Formation
-
Aug 26, 2026, 17:52Kamlesh Darji: A Practical Guide to Interpreting Coagulation Tests
-
Aug 26, 2026, 17:46Bruno Pougault: The Hidden Burden of Hemostatic Disorders in Women
-
Aug 26, 2026, 17:39Charan Gubba: Adult ITP – A major shift in the 2026 ASH Guidelines
-
Aug 26, 2026, 17:38Stephan A Mayer: Early Imaging Reveals Higher Risk of Hematoma Expansion After ICH
-
Aug 26, 2026, 17:09Kemal Karaagac: NOACs May Offer Cognitive and Clinical Benefits in AF With Alzheimer’s Disease
-
Aug 26, 2026, 16:53Chokri Ben Lamine: Antiphospholipid Syndrome After Kidney Transplantation
-
Aug 26, 2026, 16:32Kai Rejeski: Why TP53 Mutations May Define a Higher-Risk CAR-T Population
-
Aug 26, 2026, 16:20Ons Marsit: Impact of Electroanatomical Mapping on Pentaspline Pulsed Field Ablation